Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.

This ebook describes how electronic clinical outcomes assessments (eCOA), mobile digital assessments, and other innovative data capture technologies are able to “meet patients where they are” in Parkinson’s Disease trials – with increasingly objective, sensitive, and continuous measures. 

How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?

Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.

Delve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.

Unearth how this global eClinical provider delivered a decentralized platform including eSource/ePRO for direct-data-entry, randomization, eConsent, telehealth, remote monitoring, and data management.

Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.

Unearth how this global eClinical provider delivered a decentralized platform including eSource/ePRO for direct-data-entry, randomization, eConsent, telehealth, remote monitoring, and data management.

Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.